Vivos Therapeutics Inc VVOS announced two critical strategic agreements that will expand Vivos' current product line and are expected to create near-term additional revenue opportunities.
Vivos Therapeutics has executed agreements with Ormco and On Demand Orthodontist to provide Spark Clear Aligners to its national network of providers.
Up to this point, Vivos has not had a means of facilitating any sort of pricing discounts for its providers with margins for Vivos. This agreement facilitates a strong collaboration effort between Vivos and Ormco and paves the way for joint marketing and sales support from each company's field sales teams.
Using Vivos CARE devices with Spark Aligners, the company expects Vivos patients to see faster treatment times and improved predictability for positive clinical outcomes.
Also Read: A Headache-Free Future? Vivos' POD Device Slashes Migraine Symptoms by 89% in Clinical Study.
Price Action: VVOS shares are up 84.20% at $0.34 on the last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
